BRIEF-OPKO receives FDA orphan drug status to treat genetic neurological disorder
March 22, 2017 at 08:16 AM EDT
* OPKO receives FDA orphan drug status for its new oligonucleotide to treat genetic neurological disorder
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.